{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:49:44Z","timestamp":1776743384769,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.lungcan.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:39:26Z","timestamp":1628599166000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer"],"prefix":"10.1016","volume":"160","author":[{"given":"Carol C.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roula","family":"Albadine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Bigras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bojarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Cutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weei-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doha","family":"Itani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyare","family":"Izevbaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aly","family":"Karsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel R.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gefei","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariboz","family":"Rashid-Kolvear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmanjatinder S.","family":"Sekhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Stockley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danh","family":"Tran-Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjit","family":"Waghray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emina E.","family":"Torlakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Sound","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lungcan.2021.08.003_b0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","article-title":"ROS1 rearrangements define a unique molecular class of lung cancers","volume":"30","author":"Bergethon","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2021.08.003_b0010","unstructured":"Research C for DE and. FDA Approves Crizotinib Capsules. FDA 2019. Available at: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-crizotinib-capsules. Accessed January 30, 2021."},{"issue":"21","key":"10.1016\/j.lungcan.2021.08.003_b0015","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw","year":"2014","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.lungcan.2021.08.003_b0020","unstructured":"FDA Center for Drug Evaluation and Research. FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC. FDA 2019. Available at: http:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-entrectinib-ntrk-solid-tumors-and-ros-1-nsclc. Accessed December 31, 2019."},{"key":"10.1016\/j.lungcan.2021.08.003_b0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"Lindeman","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2021.08.003_b0030","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines Version 2.2020 Non-Small Cell Lung Cancer. 2019. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Accessed December 31, 2019."},{"key":"10.1016\/j.lungcan.2021.08.003_b0035","doi-asserted-by":"crossref","unstructured":"T.A. Boyle, K. Masago, K.E. Ellison, et al. ROS1 Immunohistochemistry Among Major Genotypes of Non\u2013Small-Cell Lung Cancer. Clin Lung Cancer 2015;16:106-111. Available at: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1525730414002320. Accessed March 10, 2019.","DOI":"10.1016\/j.cllc.2014.10.003"},{"key":"10.1016\/j.lungcan.2021.08.003_b0040","first-page":"131","article-title":"Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features","volume":"9","author":"Cao","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"7","key":"10.1016\/j.lungcan.2021.08.003_b0045","doi-asserted-by":"crossref","first-page":"e103333","DOI":"10.1371\/journal.pone.0103333","article-title":"Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements","volume":"9","author":"Cha","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.lungcan.2021.08.003_b0050","first-page":"2120","article-title":"Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study","volume":"14","author":"Conde","year":"2019","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2021.08.003_b0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmoldx.2019.06.006","article-title":"Comparison of in situ and extraction-based methods for the detection of ROS1 rearrangements in solid tumors","volume":"21","author":"Heydt","year":"2019","journal-title":"J. Mol. Diagn. JMD"},{"issue":"7","key":"10.1016\/j.lungcan.2021.08.003_b0060","first-page":"1204","article-title":"Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients","volume":"14","author":"Hofman","year":"2019","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study. Lung Cancer"},{"key":"10.1016\/j.lungcan.2021.08.003_b0065","article-title":"Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization","author":"Huang","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2021.08.003_b0070","first-page":"468","article-title":"Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma","volume":"28","author":"Lee","year":"2015","journal-title":"Mod. Pathol. Off. J U S Can Acad. Pathol. Inc."},{"issue":"2","key":"10.1016\/j.lungcan.2021.08.003_b0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.lungcan.2013.11.019","article-title":"On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas","volume":"83","author":"Mescam-Mancini","year":"2014","journal-title":"Lung. Cancer Amst. Neth."},{"issue":"16","key":"10.1016\/j.lungcan.2021.08.003_b0080","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1158\/1078-0432.CCR-11-3351","article-title":"Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion","volume":"18","author":"Rimkunas","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.lungcan.2021.08.003_b0085","first-page":"611","article-title":"Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer","volume":"10","author":"Rogers","year":"2015","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2021.08.003_b0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/his.13076","article-title":"Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target","volume":"70","author":"Selinger","year":"2017","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.lungcan.2021.08.003_b0095","doi-asserted-by":"crossref","first-page":"e0120422","DOI":"10.1371\/journal.pone.0120422","article-title":"Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR","volume":"10","author":"Shan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.lungcan.2021.08.003_b0100","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0b013e3182960fa7","article-title":"ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas","volume":"37","author":"Sholl","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2021.08.003_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqw201","article-title":"Immunohistochemical Detection of ROS1 Fusion","author":"Su","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2021.08.003_b0110","doi-asserted-by":"crossref","unstructured":"P. Viola, M. Maurya, J. Croud, et al. A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer. J. Thorac. Oncol. 2016;11:1029-1039. Available at: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S155608641630082X. Accessed March 10, 2019.","DOI":"10.1016\/j.jtho.2016.03.019"},{"issue":"2","key":"10.1016\/j.lungcan.2021.08.003_b0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/his.12379","article-title":"ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases","volume":"65","author":"Warth","year":"2014","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.lungcan.2021.08.003_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2582-9","article-title":"Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement","volume":"16","author":"Wu","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2021.08.003_b0125","doi-asserted-by":"crossref","unstructured":"A. Yoshida, K. Tsuta, S. Wakai, et al. Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers. Mod Pathol Off J U S Can Acad Pathol Inc. 2014;27:711-720.","DOI":"10.1038\/modpathol.2013.192"},{"key":"10.1016\/j.lungcan.2021.08.003_b0130","first-page":"1255","article-title":"Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer","volume":"9","author":"Cutz","year":"2014","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.lungcan.2021.08.003_b0135","first-page":"79","article-title":"Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine \u2013 Part 2: immunohistochemistry test performance characteristics","volume":"25","author":"Torlakovic","year":"2017","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"10.1016\/j.lungcan.2021.08.003_b0140","unstructured":"M. Varella-Garcia, A. Yoshida, (2016). IASLC ATLAS OF ALK AND ROS1 TESTING IN LUNG CANCER (M. S. Tsao, F. R. Hirsch, & Y. Yatabe (eds.); 2nd ed.), Chapter 7. Editorial Rx Press."},{"issue":"8","key":"10.1016\/j.lungcan.2021.08.003_b0145","first-page":"571","article-title":"Technical standards and guidelines: molecular genetic testing for ultra-rare disorders","volume":"7","author":"Maddalena","year":"2005","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"issue":"10","key":"10.1016\/j.lungcan.2021.08.003_b0150","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jclinpath-2017-204381","article-title":"Effect of fixation time on breast biomarker expression: a controlled study using cell line-derived xenografted (CDX) tumours","volume":"70","author":"Kao","year":"2017","journal-title":"J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.lungcan.2021.08.003_b0155","doi-asserted-by":"crossref","first-page":"e112159","DOI":"10.1371\/journal.pone.0112159","article-title":"The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization","volume":"9","author":"Tembuyser","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.lungcan.2021.08.003_b0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/PAI.0000000000000681","article-title":"NordiQC Assessments of MSH6 Immunoassays","volume":"26","author":"Vyberg","year":"2018","journal-title":"Appl. Immunohistochem. Molecul. Morphol."},{"issue":"4","key":"10.1016\/j.lungcan.2021.08.003_b0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAI.0000000000000734","article-title":"Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing","volume":"27","author":"Cheung","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.lungcan.2021.08.003_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAI.0000000000000163","article-title":"Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee","volume":"23","author":"Torlakovic","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM Off. Publ. Soc. Appl. Immunohistochem."},{"key":"10.1016\/j.lungcan.2021.08.003_b0175","doi-asserted-by":"crossref","unstructured":"S. Gupta, V. Neumeister, J. McGuire, et al. Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO\/CAP ISH group 4 breast cancer. Npj Breast Cancer 2019;5:1-8. Available at: http:\/\/www.nature.com\/articles\/s41523-019-0122-x. Accessed January 31, 2021.","DOI":"10.1038\/s41523-019-0122-x"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221004906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221004906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:57:57Z","timestamp":1759237077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500221004906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"alternative-id":["S0169500221004906"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.08.003","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}